Tenax Therapeutics, Inc.
TENX
$5.80
$0.030.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.60M | -14.56M | -12.57M | -10.10M | -7.71M |
| Total Depreciation and Amortization | -- | 5.10K | 6.10K | 7.10K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.15M | 218.90K | 243.30K | 268.10K | 216.10K |
| Change in Net Operating Assets | 1.64M | 1.88M | 870.30K | 483.30K | 1.58M |
| Cash from Operations | -14.81M | -12.46M | -11.45M | -9.34M | -5.90M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 200.00 | 200.00 | 1.80K | 3.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 200.00 | 200.00 | 1.80K | 3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -501.00K | -675.10K | -567.60K | -601.40K | -624.10K |
| Issuance of Common Stock | 100.30M | 100.30M | 8.35M | 8.42M | 14.48M |
| Repurchase of Common Stock | -100.24M | -14.19M | -14.48M | -14.48M | -14.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.30M | 14.19M | 14.13M | 14.13M | 14.19M |
| Cash from Financing | 99.87M | 99.63M | 7.44M | 7.48M | 13.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.06M | 87.17M | -4.01M | -1.87M | 7.67M |